Financhill
Back

Axsome Therapeutics 10K Form

Sell
37

AXSM
Axsome Therapeutics

Last Price:
44.94
Seasonality Move:
51.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AXSM News And Ratings

See the #1 stock for the next 7 days that we like better than AXSM

AXSM Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-33.78M
Price / Cash Flow: 0
Annual Sales: $0.38
Price / Book: 119.17

Profitability

EPS (TTM): -3.92000
Net Income (TTM): $-149.93M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Axsome Therapeutics Earnings Forecast

Key Axsome Therapeutics Financial Ratios

  • The Interest Expense is -4.37% of Operating Income.
  • Per Share Earnings over the last 9 years have been positive in 2 years.

Axsome Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: AXSM
CUSIP: 05464T
Website: axsome.com

Debt

Debt-to-Equity Ratio: 6.15
Current Ratio: 2.44
Quick Ratio: 2.1

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AXSM Technical Analysis vs Fundamental Analysis

Sell
37
Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy or a Sell?